Analysis: How private purchasers can help control healthcare costs
HFMA’s Chad Mulvany reviews results of a recent West Health and Gallup Poll survey of public opinion related to healthcare costs.
Organizations that are changing the face of the ambulatory care market
The shift to an outpatient- and consumer-driven healthcare system requires traditional providers to strategically respond to game-changing trends.
Analysis: CMMI primary care initiatives: Potential opportunity but lots of questions
The five new alternative payment models offer multiple participation options for primary care practices of different sizes with advanced capabilities.
Provider nimbleness required for diverse value-based healthcare models
Many providers are in the throes of implementing strategies for value-based health care. But now they must adapt to an environment characterized by diverse value-based care models, new players, and more data to discern provider value. To weather the next decade, the key attribute providers will need is nimbleness—a challenge in an industry not known…
Reconsidering post-acute care options
HFMA President and CEO Joe Fifer highlights the need to consider post-acute care in the context of reducing the total cost of care.
Hospitals cut safety-related patient deaths by 22% since 2016: Leapfrog
A national safety-grading group concluded that a combination of factors enabled hospitals to reduce annual safety-related deaths by 45,000, or 22%, since 2016.
Analysis: UnitedHealthcare expands MA bundled payment plan offerings for 2020
HFMA’s Chad Mulvany says UnitedHealthcare’s move to expand its bundled payment offerings to providers in its Medicare Advantage plans in more than 30 states is a step in the right direction in support of providers’ efforts to transition to value-based payment models.
Analysis: N.C. House of Representatives stalls reference-based pricing plan
HFMA’s Chad Mulvany looks at the trend of states basing (or considering basing) hospital and physician service payment rates for employees on a percentage of Medicare.
Analysis: CVS, Walgreens look to the chronically ill for a pharmacy cure
HFMA’s Chad Mulvany looks at how insurers’ claims data could be used by CVS and Walgreens walk-in clinic care teams to flag high-risk patients and provide tailored care plans.
Analysis: Controlling access to control costs
Health-plan-based primary care offerings may be challenging conventional wisdom related to population health.